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httcense.Abstract Background: Clinicians have always evaluated the degree of leukocytosis in patients with
pneumonia as an indication of systemic inﬂammatory response and severity of disease. But platelets
have been increasingly recognized as inﬂammatory cells with an important role in host defenses.
Objective: To evaluate if abnormal platelet count in hospitalized patients with CAP was associ-
ated with severity of CAP comparing it with abnormal leucocytes’ count.
Methods: The study enrolled 66 patients with community acquired pneumonia admitted to respi-
ratory ICU of Ain Shams University and Ain Shams University specialized hospitals. Data were col-
lected from each patient including demographic data, clinical ﬁndings, comorbidities, laboratory
data, arterial blood gas results, chest radiographic ﬁndings; pneumonia severity index (PSI) and
CURB-65 were calculated. Simple correlations between variables were examined by calculating
Pearson’s product correlation coefﬁcient. Four models of multiple linear regression analysis was per-
formed to study the simultaneous effects of the different data variables on PSI, CURB-65 score, need
for mechanical ventilation and length of stay in ICU as dependent variables respectively indicating
pneumonia severity.
Results: There were signiﬁcant correlations between the following: personal data, clinical
ﬁndings, arterial blood gas ﬁndings, laboratory results, radiological ﬁndings and data of severity
which are (PSI, PSI class, CURB-65 score, length of stay in ICU, mechanical ventilation)
(p< 0.001). Thrombocytosis was strongly associated with CAP severity parameters and was more
signiﬁcant than abnormal leucocytic count in predicting the severity of CAP as studied on their effectd pneumonia; PSI, pneumonia
rea P7 mmol/L, respiratory
0 mm Hg systolic or660 mm
474750.
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146 A.A. Hesham, H.A. Hebaon PSI, CURB-65 score and need for mechanical ventilation; while leucocytosis was more signiﬁcant
in predicting the length of stay in ICU than thrombocytosis.
Conclusion: Thrombocytosis can be used as a marker of severity in patients with community-
acquired pneumonia better than leucocytes’ count.
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Community-acquired pneumonia (CAP) continues to be associ-
atedwith signiﬁcantmorbidity andmortality, is ranked together
with inﬂuenza as the eighth leading cause of death in the United
States [1]. Physicians continue to be either conservative or over-
estimating the risk of death in patients with pneumonia, and
therefore affecting the decision to hospitalize many patients.
Severity scores provide pivotal direction for the management
of community-acquired pneumoniahelping guide decisions such
as the appropriate venue for care, diagnostic strategies, and anti-
biotic therapies. Fine and his colleagues [2] have provided us
with a validated evidence-based tool and amost popular severity
scores, the pneumonia severity index (PSI) which is speciﬁc for
predicting mortality, besides the British Thoracic Society’s
CURB-65 [3] (Confusion, ureaP 7 mmol/L, respiratory
rateP 30 breaths/min, blood pressure 6 90 mm Hg systolic or
660 mmHg diastolic, ageP 65 years) are accurate for predict-
ing pneumonia-relatedmortality These tools are simple to apply
andhighly useful in practice, andhave beenwidely adopted [4,5].
No matter how simple or validated a tool may be, many
physicians ﬁnd any scoring system cumbersome and would
prefer a single surrogate blood test that would allow them to
predict outcomes and to stratify risk in patients [6].
Previously, Clinicians have always evaluated the degree of
leukocytosis in patients with pneumonia as an indication of
systemic inﬂammatory response and severity of disease. But
Platelets have been increasingly recognized as an important
component of innate and adaptive immunity. Platelet response
in antimicrobial host defense is similar, in many ways, to the
leukocyte response.
Both cell types contain antimicrobial peptides that act
against a broad range of pathogens that contributes to limit-
ing the infection [7]. Therefore, Thrombocytopenia is also a
recognized marker of poor outcomes in patients with pneu-
monia, due to the association of low platelet counts with dis-
seminated intravascular coagulation and severe sepsis [8].
However, to our knowledge scanty studies investigated the
association between thrombocytosis and clinical outcomes
in adult patients with CAP [9]. Therefore, considering that
platelets play a crucial role in antimicrobial host defenses
and the coagulation system, the primary objective of this
study was to investigate the association of an abnormal plate-
let count as an important marker to assess severity of disease
in patients with CAP versus the usual counting on the total
leukocyte count.
Subjects and methods
Patients and study design
The study was conducted on 66 patients, all had community
acquired pneumonia and all were admitted to respiratory
ICU of Ain Shams University and Ain Shams Universityspecialized hospitals. Data were collected from each patient
including demographic data, clinical ﬁndings, comorbidities,
laboratory data, arterial blood gas results, chest radiographic
ﬁndings, the collected data were used to calculate the
patient’s pneumonia severity using the pneumonia severity in-
dex (PSI) and CURB-65 (confusion, urea, respiratory rate,
blood pressure, ageP 65 years). There were no exclusion
criteria.
Deﬁnitions
CAP was deﬁned as the presence of a new pulmonary inﬁltrate
on chest radiograph at the time of hospitalization associated
with at least one of the following: (1) new or increased cough,
(2) an abnormal temperature (<35.6 C or >37.8 C) and (3)
an abnormal serum leukocyte count (leukocytosis, left shift, or
leucopenia deﬁned by local laboratory values). Hypotension as
deﬁned as a systolic blood pressure 6 90 mm Hg or diastolic
blood pressure 6 60 mm Hg. Alteration of gas exchange was
deﬁned as PaO2 < 60 mm Hg or PaO2/FIO2 < 300 or O2
saturation < 90%. Thrombocytopenia and thrombocytosis
were deﬁned as platelet counts < 150,000/L or >400,000/L,
respectively. Signiﬁcant leucopenia and leukocytosis were
deﬁned asWBCcounts of<4,000 and>11,000, respectively [9].
Data analysis
Simple correlations between variables were examined by calcu-
lating Pearson’s product correlation coefﬁcient. Multiple linear
regression analysis was performed to study the simultaneous
effects of the different data variables on each parameter indi-
cating pneumonia severity as a dependent variable. Data are
presented as mean ± SD for continuous variables or fre-
quency (percentage %) for categorical variables, P< 0.05
was considered signiﬁcant. Analysis was performed using the
statistical software (SPSS version 17; SPSS, Inc., Chicago,
IL, USA).
Results
Sixty-six patients with community acquired pneumonia were
recruited from the respiratory ICU of Ain Shams University
hospital and Ain Shams University Specialized hospital. The
patient characteristic data are described in Table 1.
Data presented as mean ± SD or frequency (percentage);
SBP, systolic blood pressure; DBP, diastolic blood pressure;
ABG, arterial blood gases; ALB, albumin; HCT, hematocrit
value; TLC, total leukocytic count; PSI, pneumonia severity
index; MV, mechanical ventilation; CURB-65: confusion,
urea, respiratory rate, blood pressure, age > 65 years.
Correlations of different data with the parameters indicat-
ing severity on admission (PSI, PSI class, CURB-65 score,
length of stay in ICU, mechanical ventilation) were done using
Pearson’s product correlation. There were signiﬁcant correla-
tions between the following: personal data (age, sex, smoking
Table 1 Patient characteristics.
Age (mean ± SD) 54.32 ± 16.78
Sex Male (%) 36 (54.5)
Female (%) 30 (45.5)
Smoking Smoker (%) 39 (59.1)
Non (%) 27 (40.9)
Length of stay in ICU, d (mean ± SD) 14.11 ± 6.18
Clinical data ﬁndings:
Conscious level Conscious (%) 30 (45.5)
Disturbed (%) 36 (54.5)
Temperature (C) (mean ± SD) 39.1 ± 0.93
Respiratory rate (/min) (mean ± SD) 31 ± 5
Heart rate (/min) (mean ± SD) 118 ± 19
SBP, mmHg (mean ± SD) 103 ± 15
DBP, mmHg (mean ± SD) 66 ± 8
Severity on ICU admission:
Mechanical ventilation No MV (%) 33 (50)
MV (%) 33 (50)
PSI (mean ± SD) 149.06 ± 73.97
PSI risk class (%) I (%) 9 (13.6)
II (%) 5 (7.6)
III (%) 4 (6.1)
IV (%) 15 (22.7)
V (%) 33 (50)
CURB-65 score (%) 0 (%) 14 (21.2)
1 (%) 6 (9.1)
2 (%) 10 (15.2)
3 (%) 6 (9.1)
4 (%) 21 (31.8)
5 (%) 9 (13.6)
Arterial blood gas results:
PH (mean ± SD) 7.40 ± 0.06
PO2, mmHg (mean ± SD) 51.78 ± 13.4
PO2/FIO2 ratio (mean ± SD) 246.8 ± 64.02
Laboratory results:
ALB, mg/dl 3.3 ± 0.6
BUN, mg/dl 31 ± 9
CREAT, mg/dl 1.1 ± 0.4
NA, mg/dl 131 ± 5.8
HCT, % (%) 31.2 ± 5.8
TLC, cell/ll (mean ± SD) 16386.36 ± 5752.4
Platelets, cell/ll (mean ± SD) 402893.94 ± 175456
Radiological ﬁndings:
Distribution Localized (%) 33 (50)
Multilobar (%) 33 (50)
Side Right (%) 18 (27.3)
Left (%) 24 (36.4)
Bilateral (%) 24 (36.4)
Pleural eﬀusion Yes (%) 27 (40.9)
No (%) 39 (59.1)
Loculation Yes (%) 51 (77.3)
No (%) 15 (22.7)
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tory rate, heart rate, systolic and diastolic blood pressure),
arterial blood gas ﬁndings (PH, PO2, PO2/FIO2 ratio), labora-
tory results (BUN, creatinine, Na, hematocrit, total leucocytic
count, platelet count), radiological ﬁndings (distribution in
X-ray, side, loculation of the effusion) and data of severity
which are (PSI, PSI class, CURB-65 score, length of stay inICU, mechanical ventilation) (p< 0.001). There were no
signiﬁcant correlation between the presence of pleural effusion
and the parameters of severity of pneumonia, while albumin
level was only signiﬁcantly correlated with PSI and PSI class
(p< 0.05).
The predictors for severity of community acquired pneumo-
nia on admission to ICU were examined by using multiple
Figure 1 Multiple linear regression model on PSI, independent
variables are the personal, clinical, laboratory, arterial blood gas
and radiology data. The model is signiﬁcant (F= 857.99,
p= 0.000) with coefﬁcient of determination of 99.7%.
Figure 2 Multiple linear regression model on CURB-65 score,
independent variables are the personal, clinical, laboratory,
arterial blood gas and radiology data. The model is signiﬁcant
(F= 273.56, p= 0.000) with coefﬁcient of determination of 99%.
Figure 3 Multiple linear regression model on the need for
mechanical ventilation, independent variables are the personal,
clinical, laboratory, arterial blood gas and radiology data. The
model is signiﬁcant (F= 290.18, p= 0.000) with coefﬁcient of
determination of 99%.
Figure 4 Multiple linear regression model on the length of stay
in ICU, independent variables are the personal, clinical, labora-
tory, arterial blood gas and radiology data. The model is
signiﬁcant (F= 123.44, p= 0.000) with coefﬁcient of determina-
tion of 97.7%.
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monia as a dependent factor for each model; and including all
the personal, clinical, laboratory, arterial blood gas and radiol-
ogy data as independent variables.
The ﬁrst multiple linear regression model used PSI as a
dependent variable, it was signiﬁcant (F= 857.99, p= 0.000)
and accounts for 99.7%of estimation of PSI. Themost powerful
predictor was altered conscious level followed by platelet count,
while total leucocytic count had no signiﬁcant effect
(p= 0.137); this is presented in Fig. 1.
The second linear regression model used CURB-65 score as
a dependent variable, it was signiﬁcant (F= 273.56, p=
0.000) and accounts for 99% of prediction of CURB-65 score.
The most powerful predictor was platelet count while TLC was
very less signiﬁcant. It is illustrated in Fig. 2.
The third linear regression model included mechanical ven-
tilation as a dependent variable, the model was signiﬁcant
(F= 290.18, p= 0.000) and it explains 99% of the need for
mechanical ventilation; platelet count was the most signiﬁcant
independent factor and TLC was very less signiﬁcant in predic-
tion of the need for mechanical ventilation; the model is
presented in Fig. 3.
The last regression model used the length of stay in ICU as
a dependent variable, this model is signiﬁcant (F= 123.44,
p= 0.000) and it accounts for 97.7% of prediction of the
length of stay in ICU, in contrast to the previous models,
platelet count has no signiﬁcant effect while the TLC was
one of the most powerful predictors. The model is shown in
Fig. 4.
Discussion
Accurate assessment the severity of pneumonia is the key to
managing patients with CAP appropriately. In this study, con-
ducted in a cohort of patients hospitalized in ICU with CAP,
estimation of the PSI and CURB-65 scores were performed,
regarding that several previous studies have shown that the
PSI and CURB-65 appropriately stratify severity, the need
for mechanical ventilation and the duration of hospital stay
[4,10].
In our study the predictors for severity of CAP on admission
to ICU was examined by using multiple linear regression
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able; the most powerful predictor was altered conscious level
followed by platelet count, while total leucocytes’ count had
no signiﬁcant effect (p> 0.05), these results agree with the pre-
vious study which indicated that thrombocytopenia and throm-
bocytosis are signiﬁcantly associated with mortality in patients
with CAP, therefore at time of hospitalization, abnormalities in
platelet count are better predictors of clinical outcomes in pa-
tients with CAP when compared with abnormalities in leuko-
cyte count. Besides, in the multivariable logistic regression
model, mortality in hospitalized patients with CAP is associated
with severity of disease but it is also independently associated
with elevated platelet count [9].
The second model used CURB-65 score as a dependent var-
iable; the most powerful predictor was platelet count while
TLC was very less signiﬁcant. Similarly two prior studies, both
in pediatric patients, reported an association between throm-
bocytosis and poor outcomes in patients with CAP [11,12].
The third linear regression model included mechanical
ventilation as a dependent variable, platelet count was the
most signiﬁcant independent factor and TLC was very less sig-
niﬁcant in prediction of the need for mechanical ventilation.
Two possible pathophysiological mechanisms may explain
our study ﬁndings, platelets are important inﬂammatory cells
that can undergo chemotaxis and are able to release numerous
proinﬂammatory molecules [13]. In patients with CAP there is
an association between levels of inﬂammatory cytokines and
severity of disease [14]. It can be theorized that thrombocytosis
may favor an exaggerated systemic inﬂammatory response
that, in turn, produces poor outcomes in patients with CAP.
Besides this mechanism of platelet induced systemic inﬂamma-
tion, another possible mechanism is platelet-induced thrombus
formation which is a risk factor for pulmonary thromboembo-
lism and acute myocardial infarction and cerebrovascular
stroke that also may add on risk of mortality [9,15].
In contrast to the previous models, the model used the
length of stay in ICU as a dependent variable; in this model
platelet count has no signiﬁcant effect while the TLC was
one of the most powerful predictors. These results found as
regards duration of hospital stay are affected by other factors,
such as the causal microorganism, comorbidities and treat-
ment-related factors which are not included in our study.
[16] Therefore, it must be noted that the initial severity of
CAP is an only one factor predicting treatment failure which
in turn increase duration of hospital stay.
In summary, the initial assessment of a patient with pneu-
monia, it is mandatory to consider thrombocytosis as a predic-
tive factor for severity of pneumonia. Moreover, when
evaluating a complete blood count report in patients with
CAP, platelet count may be more informative for predicting
patient poor outcomes than the more commonly used
leukocyte count.References
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